Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2017.00835
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

Limited Extent of Pleiotropic Effects Mediated by Dipeptidyl Peptidase-4 Inhibitors in Patients With Diabetes Mellitus

Circulation Journal
MedicineCardiovascular MedicineCardiology
2018English

Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2007English

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients With Type 2 Diabetes

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Acquired Hemophilia a Associated With Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Comparing Treatment Intensification and Clinical Outcomes of Metformin and Dipeptidyl Peptidase‐4 Inhibitors in Treatment Naïve Patients With Type 2 Diabetes in Japan

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy